Clear Harbor Asset Management LLC bought a new position in Aemetis, Inc. (NASDAQ:AMTX – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 16,475 shares of the specialty chemicals company’s stock, valued at approximately $44,000.
Several other large investors have also recently bought and sold shares of AMTX. FMR LLC raised its position in shares of Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after buying an additional 9,137 shares in the last quarter. Barclays PLC raised its holdings in shares of Aemetis by 274.6% in the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after acquiring an additional 34,816 shares in the last quarter. Rhumbline Advisers grew its holdings in shares of Aemetis by 2,837.1% during the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 50,528 shares in the last quarter. Wellington Management Group LLP purchased a new position in shares of Aemetis during the third quarter worth about $177,000. Finally, Bank of New York Mellon Corp bought a new position in shares of Aemetis in the second quarter worth approximately $306,000. 27.02% of the stock is owned by institutional investors.
Aemetis Stock Performance
Shares of AMTX opened at $2.15 on Thursday. Aemetis, Inc. has a fifty-two week low of $2.04 and a fifty-two week high of $7.03. The firm has a market cap of $106.94 million, a price-to-earnings ratio of -0.95 and a beta of 1.47. The firm has a 50 day moving average price of $3.16 and a 200-day moving average price of $2.95.
Analyst Ratings Changes
A number of research firms have commented on AMTX. StockNews.com raised shares of Aemetis to a “sell” rating in a research note on Friday, January 3rd. HC Wainwright reiterated a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research report on Monday, December 23rd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $12.95.
View Our Latest Stock Analysis on AMTX
About Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Further Reading
- Five stocks we like better than Aemetis
- Market Cap Calculator: How to Calculate Market Cap
- Oracle Announces Game-Changing News for the AI Industry
- Stock Average Calculator
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding AMTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aemetis, Inc. (NASDAQ:AMTX – Free Report).
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.